Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05602376 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Improving HIV Testing, Linkage, and Retention in Care for Men Through U=U Messaging

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Re-verified, no change to tracked fieldsv5
  2. Enrollment target: 23188 to 3642v4
  3. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Mar 20, 2023 to Mar 31, 2023
    • Site details revised at 2 of 2 sites
    v3
  4. Start date: Feb 1, 2023 to Mar 20, 2023v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study will evaluate the impact of U=U messaging and counseling on gaps in the HIV care cascade for men, including testing uptake and ART initiation (Aim 1), achieving viral suppression and retention in care (Aim 2) in two provinces in South Africa. The U=U message communicates the compelling idea that PLHIV who take ART and have an undetectable viral load (\<200 copies/mL) cannot sexually transmit HIV. Additionally, the investigators will conduct a multi-method evaluation to inform future implementation of U=U messaging interventions (Aim 3).
Trial Details
NCT Number NCT05602376
Lead Sponsor Desmond Tutu HIV Foundation
Collaborators: National Institute of Mental Health (NIMH), National Institutes of Health (NIH), University of Pennsylvania
Conditions
(from sponsor)		 HIV Infections, Men, Treatment Adherence
Related terms HIV Infections, Multiple Endocrine Neoplasia Type 1, Treatment Adherence and Compliance
Enrollment 3,642 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov